explore -WSS

explore

author：focus 2025-09-30 08:52:15 - browse：2762

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

WSS

Federal judge rules Oregon’s tough new gun law is constitutional

Why police arrested suspected Gilgo Beach killer away from his house

Argenx drug significantly slows progression of nerve disorder

Hospitals warn Medicare's drug payment fix is ‘unlawful’

FDA has safety concerns on CRISPR

Who gets to use the title 'doctor'?

leisure time

explore

hotspot

What does generative AI mean for health care? We asked experts

Meta's Zuckerberg and Chan on track to put $50 billion into science

Apple is now the first public company to be valued at $3 trillion

J&J expands global access to TB drug amid advocacy campaign

The cancer drug shortage isn’t new — and neither are the solutions

Why police arrested suspected Gilgo Beach killer away from his house

United colonoscopy coverage change 'may cost lives,' doctors say

Telehealth options flood the market as retailers push virtual care

How one medical school became remarkably diverse

Celiac disease study examines precisely how gluten triggers injury

hotspot

Chimpanzees, like humans and whales, get menopause: Study

Medtronic CEO on promising devices for diabetes, hypertension

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Who gets to use the title 'doctor'?

Federal judge rules Oregon’s tough new gun law is constitutional

focus

focus

entertainment

focus